# FDA recall D-1495-2022

> **Akorn, Inc.** · Class II · drug recall initiated 2022-08-31.

## Product

Lidocaine Hydrochloride Jelly USP, 2%,  Sterile, 30mL tube, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-711-31

## Reason for recall

cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

## Distribution

USA nationwide

## Key facts

- **Recall number:** D-1495-2022
- **Recalling firm:** Akorn, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-08-31
- **Report date:** 2022-09-14
- **Termination date:** 2024-06-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Gurnee, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1495-2022

## Citation

> AI Analytics. FDA recall D-1495-2022. Retrieved 2026-06-12 from https://api.ai-analytics.org/recall/D-1495-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*